Min Chul Park, Ph.D.
Board Member
ZyVersa Therapeutics, Inc. (ZVSA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Min Chul Park, Ph.D.
Min Chul Park, Ph.D. is recorded as Board Member at ZyVersa Therapeutics, Inc. (ZVSA). ZyVersa Therapeutics, Inc. reported in an 8-K filed July 10, 2026 that Min Chul Park, Ph.D. resigned as independent director, effective July 8, 2026. ZyVersa Therapeutics, Inc. reported in an 8-K filed October 30, 2024 that Min Chul Park, Ph.D. was appointed Class II Director, effective October 29, 2024.
“On July 8, 2026, Min Chul Park, Ph.D., notified the Board of Directors (the "Board") of ZyVersa Therapeutics, Inc. (the "Company") of his intention to resign from his Board positions as an independent director, member of the Compensation Committee of the Board, and member of the Nominating and Corporate Governance Committee of the Board. Dr. Park's resignation has been accepted by the Board, effective immediately.”
“With respect to Proposal No. 1, stockholders elected the Class II director nominee (Min Chul Park, Ph.D.) to hold office for a term of three years and until a successor is duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-10-29–present
-
2024-10-29–2026-07-08
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at ZyVersa Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Stephen C. Glover CEO, Board Member
- Peter Wolfe CFO
- Daniel J. O'Connor Board Member
- Gregory Freitag Board Member
- James Sapirstein Board Member
- Katrin Rupalla Board Member
- Min-Chul Park Board Member
- Rob G. Finizio Board Member
- Robert Finizio Board Member
- Robert G. Finizio Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.